Role of peroxisome proliferator-activated receptor alpha (PPARα) and PPARα-mediated species differences in triclosan-induced liver toxicity

被引:20
|
作者
Tang, Yangshun [1 ]
Vanlandingham, Michelle M. [1 ]
Wu, Yuanfeng [1 ]
Beland, Frederick A. [1 ]
Olson, Greg R. [2 ]
Fang, Jia-Long [1 ]
机构
[1] US FDA, Div Biochem Toxicol, NCTR, 3900 NCTR Rd, Jefferson, AR 72079 USA
[2] US FDA, Toxicol Pathol Associates Inc, NCTR, 3900 NCTR Rd, Jefferson, AR 72079 USA
关键词
Triclosan; PPAR; Liver toxicity; Peroxisome; Cell proliferation; FACTOR-KAPPA-B; METABOLISM; AGE; HEPATOCARCINOGENESIS; MOUSE; GAMMA; ACID;
D O I
10.1007/s00204-018-2308-7
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Triclosan, a widely used broad spectrum anti-bacterial agent, is hepatotoxic in rodents and exhibits differential effects on mouse and human peroxisome proliferator-activated receptor alpha (PPAR) in vitro; however, the mechanism underlying triclosan-induced liver toxicity has not been elucidated. This study examined the role of mouse and human PPAR in triclosan-induced liver toxicity by comparing the effects between wild-type and PPAR-humanized mice. Female mice of each genotype received dermal applications of 0, 58, or 125mg triclosan/kg body weight daily for 13 weeks. Following the treatment, triclosan caused an increase in liver weight and relative liver weight only in wild-type mice. The expression levels of PPAR target genes cytochrome P450 4A and acyl-coenzyme A oxidase 1 were increased in livers of both wild-type and PPAR-humanized mice, indicating that triclosanactivated PPAR. Triclosan also elevated the expression levels of peroxisomal membrane protein PMP70 and catalase in the livers of both genotypes, suggesting that triclosan promoted the production of hepatocyte peroxisomes. There was an enhanced expression of cyclin D1, c-myc, proliferating cell nuclear antigen, and Ki67, and a higher percentage of BrdU-labeled hepatocytes in wild-type mice, but not in PPAR-humanized mice, demonstrating triclosan-activated PPAR had differential effects on the hepatocyte proliferation. These findings imply that the differential effects of triclosan-activated PPAR on cell proliferation may play a role in the species differences in triclosan-induced liver toxicity.
引用
收藏
页码:3391 / 3402
页数:12
相关论文
共 50 条
  • [41] Peroxisome proliferator-activated receptor (PPAR) agonists as a potential therapy for inherited metabolic disorders
    Seminotti, Bianca
    Grings, Mateus
    Vockley, Jerry
    Leipnitz, Guilhian
    BIOCHEMICAL PHARMACOLOGY, 2023, 209
  • [42] Peroxisome proliferator-activated receptor gamma (PPARγ) regulates lactase expression and activity in the gut
    Fumery, Mathurin
    Speca, Silvia
    Langlois, Audrey
    Davila, Anne-Marie
    Dubuquoy, Caroline
    Grauso, Marta
    Mena, Anthony Martin
    Figeac, Martin
    Metzger, Daniel
    Rousseaux, Christel
    Colombel, Jean-Frederic
    Dubuquoy, Laurent
    Desreumaux, Pierre
    Bertin, Benjamin
    EMBO MOLECULAR MEDICINE, 2017, 9 (11) : 1471 - 1481
  • [43] Peroxisome proliferator-activated receptor (PPAR)γ is highly expressed in normal human pituitary gland
    Bogazzi, F
    Russo, D
    Locci, MT
    Chifenti, B
    Ultimieri, F
    Raggi, F
    Viacava, P
    Cecchetti, D
    Cosci, C
    Sardella, C
    Acerbi, G
    Gasperi, M
    Martino, E
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2005, 28 (10) : 899 - 904
  • [44] Peroxisome proliferator-activated receptor (PPAR)γ is highly expressed in normal human pituitary gland
    F. Bogazzi
    D. Russo
    M. T. Locci
    B. Chifenti
    F. Ultimieri
    F. Raggi
    P. Viacava
    D. Cecchetti
    C. Cosci
    C. Sardella
    G. Acerbi
    M. Gasperi
    E. Martino
    Journal of Endocrinological Investigation, 2005, 28 : 899 - 904
  • [45] Activation of Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) in Keratinocytes by Endogenous Fatty Acids
    Zhu, Bokai
    Zhu, Xiaoyang
    Borland, Michael G.
    Ralph, Douglas H.
    Chiaro, Christopher R.
    Krausz, Kristopher W.
    Ntambi, James M.
    Glick, Adam B.
    Patterson, Andrew D.
    Perdew, Gary H.
    Gonzalez, Frank J.
    Peters, Jeffrey M.
    BIOMOLECULES, 2024, 14 (06)
  • [46] Design and Synthesis of Peroxisome Proliferator-activated Receptor (PPAR) Delta Agonists and Its Implication to the Driving Force to Elicit PPAR Delta Selectivity
    Kasuga, Jun-ichi
    Oyama, Takuji
    Nakagome, Izumi
    Aoyama, Atsushi
    Sako, Kumiko
    Makishima, Makoto
    Hirono, Shuichi
    Morikawa, Kosuke
    Hashimoto, Yuichi
    Miyachi, Hiroyuki
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2009, 129 (06): : 709 - 718
  • [47] Peroxisome Proliferator-Activated Receptor (PPAR) in Metabolic Syndrome and Type 2 Diabetes Mellitus
    Jay, Mollie A.
    Ren, Jun
    CURRENT DIABETES REVIEWS, 2007, 3 (01) : 33 - 39
  • [48] Peroxisome Proliferator-Activated Receptor (PPAR) Agonists as Promising New Medications for Drug Addiction: Preclinical Evidence
    Le Foll, Bernard
    Di Ciano, Patricia
    Panlilio, Leigh V.
    Goldberg, Steven R.
    Ciccocioppo, Roberto
    CURRENT DRUG TARGETS, 2013, 14 (07) : 768 - 776
  • [49] It takes two peroxisome proliferator-activated receptors (PPAR-β/δ and PPAR-γ) to tango idiopathic pulmonary fibrosis
    Boateng, Eistine
    Bonilla-Martinez, Rocio
    Ahlemeyer, Barbara
    Garikapati, Vannuruswamy
    Alam, Mohammad Rashedul
    Trompak, Omelyan
    Oruqaj, Gani
    El-Merhie, Natalia
    Seimetz, Michael
    Ruppert, Clemens
    Guenther, Andreas
    Spengler, Bernhard
    Karnati, Srikanth
    Baumgart-Vogt, Eveline
    RESPIRATORY RESEARCH, 2024, 25 (01)
  • [50] Sorting out the functional role(s) of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in cell proliferation and cancer
    Peters, Jeffrey M.
    Gonzalez, Frank J.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2009, 1796 (02): : 230 - 241